Literature DB >> 2618782

Outcome of panic and depression in a seven-year follow-up: results of the Zurich study.

M Vollrath1, J Angst.   

Abstract

In this study, the association and outcome of panic and depression were investigated in an epidemiological cohort of young adults interviewed at age 21, 23, and 28. The prevalence rates of sporadic panic, panic disorder, major depression, and recurrent brief depression were very stable. There was a clear preponderance of females in all diagnoses. Panic and depression overlapped to a large extent cross-sectionally at all 3 interviews, and this overlap increased in a longitudinal perspective. For the analysis of outcome, the subjects were divided into 4 groups according to their diagnosis at the first interview: pure panic, pure depression, mixed panic and depression, and controls. Irrespective of the first diagnosis, the 7-year outcome showed a strong tendency to develop into pure depression or mixed panic and depression at follow-up interviews. In a longitudinal perspective, cases that suffered from both panic and depression appeared more severely ill, as expressed in very high treatment rates and a high rate of lifetime suicide attempts.

Entities:  

Mesh:

Year:  1989        PMID: 2618782     DOI: 10.1111/j.1600-0447.1989.tb03031.x

Source DB:  PubMed          Journal:  Acta Psychiatr Scand        ISSN: 0001-690X            Impact factor:   6.392


  13 in total

1.  Lifetime and six-month prevalence of mental disorders in the Munich Follow-Up Study.

Authors:  H U Wittchen; C A Essau; D von Zerssen; J C Krieg; M Zaudig
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  1992       Impact factor: 5.270

2.  Prospective studies of cothymia (mixed anxiety-depression): how do they inform clinical practice?

Authors:  P Tyrer; H Seivewright; S Simmonds; T Johnson
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2001       Impact factor: 5.270

3.  Psychopathology in Dutch young adults: enduring or changeable?

Authors:  R F Ferdinand; F C Verhulst
Journal:  Soc Psychiatry Psychiatr Epidemiol       Date:  1995-03       Impact factor: 4.328

4.  Psychosocial features associated with lifetime comorbidity of major depression and anxiety disorders among a community sample of mid-life women: the SWAN mental health study.

Authors:  Jill M Cyranowski; Laura L Schott; Howard M Kravitz; Charlotte Brown; Rebecca C Thurston; Hadine Joffe; Karen A Matthews; Joyce T Bromberger
Journal:  Depress Anxiety       Date:  2012-08-28       Impact factor: 6.505

5.  The Zurich Study. IX. Panic disorder and sporadic panic: symptoms, diagnosis, prevalence, and overlap with depression.

Authors:  M Vollrath; R Koch; J Angst
Journal:  Eur Arch Psychiatry Neurol Sci       Date:  1990

6.  A study of panic patients with and without depression.

Authors:  K Srinivasa; Iby Neerakal
Journal:  Indian J Psychiatry       Date:  2002-07       Impact factor: 1.759

7.  The Netherlands Study of Depression and Anxiety (NESDA): rationale, objectives and methods.

Authors:  Brenda W J H Penninx; Aartjan T F Beekman; Johannes H Smit; Frans G Zitman; Willem A Nolen; Philip Spinhoven; Pim Cuijpers; Peter J De Jong; Harm W J Van Marwijk; Willem J J Assendelft; Klaas Van Der Meer; Peter Verhaak; Michel Wensing; Ron De Graaf; Witte J Hoogendijk; Johan Ormel; Richard Van Dyck
Journal:  Int J Methods Psychiatr Res       Date:  2008       Impact factor: 4.035

Review 8.  Suicide and antidepressants.

Authors:  S A Montgomery
Journal:  Drugs       Date:  1992       Impact factor: 9.546

9.  DSM-III mental disorders in general medical sector: a follow-up and incidence study over a two-year period.

Authors:  G Berti Ceroni; F Berti Ceroni; R Bivi; M A Corsino; P De Marco; E Gallo; G Giovannini; S Gherardi; A Pezzoli; P Rucci
Journal:  Soc Psychiatry Psychiatr Epidemiol       Date:  1992-10       Impact factor: 4.328

10.  Prospective follow-up study lasting 2 years in patients with panic disorder with and without depressive disorders.

Authors:  G Scheibe; M Albus
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  1994       Impact factor: 5.270

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.